Diana Merino
Gerontology · Linden, NJNPI 1275216921
Payments from drug & device makers
Across 63 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$330
- Otsuka America Pharmaceutical, Inc.$127
- Exact Sciences$93
- Novo Nordisk$88
- Bayer$74
- AbbVie$72
- plus $390 from 14 others
What the payments were for
- Food & beverage$1,174100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 15 | $330 |
| Otsuka America Pharmaceutical, Inc. | 7 | $127 |
| Exact Sciences | 4 | $93 |
| Novo Nordisk | 4 | $88 |
| Bayer | 4 | $74 |
| AbbVie | 4 | $72 |
| Paratek Pharmaceuticals, Inc. | 4 | $63 |
| Lilly USA, LLC | 4 | $55 |
| Lundbeck LLC | 3 | $49 |
| Novartis | 2 | $36 |
| AstraZeneca | 2 | $32 |
| GSK | 2 | $31 |
| Dexcom, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
| Medicure Pharma Inc. | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$121
How this compares
$1,174 in reported general payments places this provider in the 75th percentile of 374 gerontology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 102 | $60,979 |
| OzempicSemaglutide | 27 | $26,539 |
| JanuviaSitagliptin Phosphate | 17 | $11,686 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,781 |
| JardianceEmpagliflozin | 13 | $9,515 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 29 | $5,636 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 39 | $4,254 |
| Mirtazapine | 94 | $3,629 |
| Memantine Hcl | 63 | $3,580 |
| Wixela InhubFluticasone Propion/Salmeterol | 19 | $3,126 |
| Atorvastatin Calcium | 200 | $2,628 |
| Amlodipine Besylate | 146 | $2,285 |
| Escitalopram Oxalate | 72 | $2,215 |
| Divalproex Sodium | 74 | $1,998 |
| Memantine Hcl ErMemantine Hcl | 15 | $1,987 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $88 | $26,53927 claims |
| MerckJanuvia | $14 | $11,68617 claims |
| GSKTrelegy Ellipta | $31 | $9,78114 claims |
| Lilly USA, LLCOlanzapine | $55 | $89812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 374 gerontology providers in New Jersey.
Other gerontology in Linden
- Lisa MalakToms River$162K
- Dana JonesTeaneck$150K
- Jennifer FoxFlemington$76K
- Susan HermidaBrick$33K
- Jihane SaadeNorth Bergen$9K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.